Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Microarray analysis in Alzheimer's disease and normal aging.

Roberta Ricciarelli1, Cristina d'Abramo, Sara Massone

  • 1Department of Experimental Medicine, University of Genoa, via L.B. Alberti 2, 16132 Genoa, Italy. ricciarelli@medicina.unige.it

IUBMB Life
|September 17, 2004
PubMed
Summary

Researchers investigated gene expression in Alzheimer's disease (AD) brains. They found increased interferon-induced protein 3 expression, a novel finding for this neurodegenerative disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The PDE5 inhibitor vardenafil enhances glutamatergic transmission through amyloid-beta and cellular prion protein.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics·2026
Same author

Impact of anticancer drugs on human Tenon's fibroblast proliferation: implications for glaucoma surgery.

BMJ open ophthalmology·2026
Same author

Prophylactic PDE4 and PDE4B inhibition reduce lesion size and neutrophil infiltration following ischemic stroke in male mice.

Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism·2025
Same author

Erectile Dysfunction Drugs as Potential Therapy for Cognitive Decline: Preclinical and Translational Evidence.

Cells·2025
Same author

Non-Electrophilic Activation of NRF2 in Neurological Disorders: Therapeutic Promise of Non-Pharmacological Strategies.

Antioxidants (Basel, Switzerland)·2025
Same author

AAV-mediated peripheral scFv's administration to reduce cerebral tau in adult P301S transgenic mice: Mono-vs. combination therapy.

Molecular therapy. Methods & clinical development·2025

Area of Science:

  • Neuroscience
  • Genetics
  • Molecular Biology

Background:

  • Alzheimer's disease (AD) is the most common form of dementia.
  • Understanding gene expression changes in AD is crucial for identifying disease mechanisms.
  • Amyloid plaques are a hallmark of AD, but their presence alone does not confirm cognitive decline.

Purpose of the Study:

  • To investigate differential gene expression in the cerebral cortex of Alzheimer's disease patients compared to normal aging.
  • To identify genes specifically related to neurodegeneration in AD.
  • To explore the role of novel proteins in the pathogenesis of AD.

Main Methods:

  • Utilized microarray technology to compare the expression profiles of 12,000 human genes.
  • Analyzed cerebral cortex tissue from AD patients and cognitively normal elderly subjects with amyloid plaques.

Related Experiment Videos

  • Employed Reverse Transcription Polymerase Chain Reaction (RT-PCR) to validate microarray findings for selected genes.

    • Main Results:

    • Identified 314 differentially expressed genes in the AD cerebral cortex.
    • Observed significant expression differences (greater than 5-fold) in 25 genes.
    • Confirmed increased expression of interferon-induced protein 3 in AD brains via RT-PCR.

    Conclusions:

    • Gene expression profiling reveals significant alterations in the AD brain.
    • Interferon-induced protein 3 is upregulated in Alzheimer's disease, suggesting a potential role in neurodegeneration.
    • This finding introduces a novel molecular target for further investigation in AD research.